ilovetech
2 minutes ago
antihama - There was an interview with LL a while back, where regulators welcomed industry expert input, as part of the FDA's efforts to establish new guidance for reviewing immunotherapy treatments, if I recall correctly. LL had thrown shade on the statistical gymnastics applied to the NVCR GBM tri